Emraclidine was expected to be a blockbuster drug for AbbVie, and this development didn’t sit well with investors.

World shares are mostly lower after the Federal Reserve cut interest rates again to ease pressure on the U.S. economy.

Wall Street rose modestly in early trading Thursday as more corporate earnings are released ahead of another inflation update ...

Schrödinger Inc.’s stock soared 14% Tuesday to put in on track for its biggest one-day gain in a year, after the company said ...

The Chiefs stayed unbeaten on a walk-off blocked field goal, and the Steelers outlasted the Commanders to take over first ...

It surged 69% higher to 338.5 billion yen ($2.2 billion ... The Motley Fool has a disclosure policy. 1 Magnificent Stock-Split Stock That's a No-Brainer Buy Right Now and 1 to Avoid at All ...

It surged 69% higher to 338.5 billion yen ($2.2 billion ... such as Take-Two Interactive's Grand Theft Auto. The Motley Fool Stock Advisor analyst team just identified what they believe are ...

Tesla shares have shot up nearly 30% since the Nov 5 election, adding over US$200 billion to its market value. Read more at ...

It surged 69% higher to 338.5 billion yen ($2.2 billion ... On rare occasions, our expert team of analysts issues a “Double Down” stock recommendation for companies that they think are ...

The first step in checking if the stock market is open is knowing the regular trading hours. Regular stock market trading hours for the NYSE and Nasdaq Stock Exchanges are weekdays from 9:30 a.m ...

Shares of the pharmacy and healthcare company are falling Friday, down 5.4% after CVS announced leadership changes and lowered guidance for the fourth time this year, weighed down by challenges in ...